Blog

A New Rare Cancer Partnership

How do you define a rare cancer?

This is one the most commonly asked questions we receive- and the answer isn’t a simple one. While the default factor cited usually involves the number of patients affected by the disease, that can vary dramatically, from as few as a handful of people a year to as many as 20,000. As a result, the most definitive criteria are often determined by the treatment and research landscape: Continue reading

Rare Disease Week on Capitol Hill 2017

Citizen Advocacy – DC legislators welcome our passionate voices during Rare Disease Week 2017

by Bill Drake, TargetCancer Foundation Advocacy Council Member and Rare Disease Advocate 

While my esophageal cancer remains in a state of remission, I’ve been seeking opportunities to help support the efforts of organizations like TargetCancer Foundation. Continue reading

Endurance Test: Overcoming Obstacles in the Run to Support TargetCancer

By Karen Dempsey, TargetCancer Foundation Advocacy Council Member

How do you push through injury, illness, and a bitter cold winter to train for your first marathon?

For Martin Arts, the answer is straightforward: He promised he’d do it. Continue reading

Keytruda – what a 40% response rate has meant to me.

By Bill Drake, TargetCancer Foundation Advocacy Council Member

On September 11, 2013 I was diagnosed with an adenocarcinoma malignant tumor on my esophagus at my GI junction, inside my GI specialist’s office on Cape Cod. I was there for my routine “over 50” colonoscopy. Continue reading

A Marathon Run Against Cholangiocarcinoma

By Karen Dempsey, TargetCancer Foundation Advocacy Council Member

As Lauren Sanford and her fiancé, DJ Webster, plan their upcoming wedding — and their life together — they have much to celebrate. They’re surrounded by the love of good friends and family, and memories of their childhoods in Saugus, Massachusetts, the town where both grew up. Continue reading

Washington DC Recap: ACA Repeal and Its Impact on Cancer Patients

By TargetCancer Foundation Advocacy Council Member DJ Webster

Last Thursday, TargetCancer Foundation traveled to Washington D.C. for the annual in-person meeting of the Deadliest Cancers Coalition, a collaboration of national non-profit organizations that TargetCancer is a member of. The DCC is focused on addressing policy issues related to our nation’s deadliest (or recalcitrant) cancers, defined as those that have five-year survival rates below 50 percent, which includes both esophageal cancer and cholangiocarcinoma. Continue reading

Team TargetCancer Foundation 2017 Runner Profile: Daniel Rothenberg

By TargetCancer Foundation Advocacy Council Member Kim Balkus

Every marathon runner has a unique story. But very few runners not only know how to complete a 26.2 mile run, but also know their way around a scientific laboratory. Expertise in both areas gives Team TargetCancer Foundation member Daniel Rothenberg a unique perspective on the importance of the research funds he is raising through his 2017 marathon run. Continue reading

Looking back at 2016

As 2016 draws to a close, we are proud to look back on an outstanding year of new programs and research success for TargetCancer Foundation. Continue reading

Supporting Those Facing Cancer During the Holidays

By Leslie Condon, TargetCancer Foundation Advocacy Council Co-Chair

The holidays can be a challenging time for those facing cancer and their families. If you or someone you know wishes to give support to individuals and families who have been affected by cancer, consider these ideas: Continue reading

Remembering Loved Ones During the Holidays

By Leslie Condon, TargetCancer Foundation Advocacy Council Co-Chair

The holidays can trigger a lot of memories and emotions for family, especially for those who have lost a loved one. Reaching out to friends and family during this time can be especially meaningful and helpful to the grieving process. If someone you love is grieving, make an effort to connect with them. Some ideas for remembering a loved one during the holidays: Continue reading